Hypernatraemia in very low birth weight infants admitted at Chris Hani Baragwanath academic hospital: incidence, fluid management and outcome by Barnard, Kim
i 
 
HYPERNATRAEMIA IN VERY LOW BIRTH WEIGHT INFANTS 
ADMITTED AT CHRIS HANI BARAGWANATH ACADEMIC 
HOSPITAL: INCIDENCE, FLUID MANAGEMENT AND OUTCOME 
 
Dr Kim Barnard 
 
 
 
 
 
 
 
 
A research report submitted to the Faculty of Health Sciences, University of the 
Witwatersrand, Johannesburg, in partial fulfilment of the requirements for the degree of 
Master of Medicine in the Branch of Paediatrics 
Johannesburg 2015 
 
  
ii 
 
DECLARATION 
I, Kim Barnard, declare that this research report is my own work. It is being submitted for 
the degree of Master of Medicine in the branch of Paediatrics, in the University of the 
Witwatersrand, Johannesburg. It has not been submitted before for any degree or 
examination at this or any other university. 
 
........................................................ 
On this... 18th  day of  February 2015 
 
 
  
iii 
 
DEDICATION 
For 
My Husband, Dr Stephen Smith 
Without whom this would never have been possible 
 
 
  
iv 
 
ABSTRACT  
Background: Fluid-management in very-low-birth-weight infants (VLBWI) with 
hypernatraemia is critical in reducing morbidity and mortality in these infants.   
Aim:  To determine incidence, fluid-management and mortality-rate in VLBWI with 
hypernatraemia.   
Methods: A retrospective descriptive study. Hospital records of VLBWI diagnosed with 
hypernatraemia during the first 72 hours of life were reviewed. Data collected included 
maternal and infant characteristics, type and volume of fluid administered on admission 
and at diagnosis, environment in which infants were nursed, time to resolution of 
hypernatraemia and mortality-rate at 28 days of life.  
Results: Of the 443 VLBWI born during June-December 2012, 370 files were retrieved, of 
which 125 infants had hypernatraemia, an incidence of 33.8%. All were started on a 
sodium-containing fluid on admission, at a volume of 60-110 ml/kg/day. Fluid-increases in 
response to hypernatraemia were 45-90 ml/kg.  Calculation of fluid-increases was based on 
a formula for water-deficit in 75% of VLBWI.  Severity of hypernatraemia was not 
associated with birthweight (p=0.26), gestational age (p=0.31) or amount of sodium infants 
were receiving at diagnosis (p=0.58).  Common fluid used for correction was 5% dextrose. 
The correction-rate was fast at >1mmol/hr in 8.4% of patients. The average-time to 
resolution was 44 hours. The average-time to resolution was longer for infants nursed in an 
incubator compared to a radiant warmer (49.7 vs. 37.7 hours, p=0.037) and in those nursed 
under phototherapy (45.6 vs. 40.8 hours, p =0.031). The mortality-rate at 28 days was 
22.5%.  
Conclusion:  The incidence of hypernatraemia in VLBWI at Chris Hani Baragwanath 
Academic Hospital is high. Fluid-management to correct hypernatraemia was appropriate 
for most infants.  
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1.0  INTRODUCTION 
Ongoing advances in neonatal medicine have significantly improved the survival rate of 
very low birth weight infants (VLBWI).1 VLBWI are defined as those neonates with a 
birth weight less than 1500g, and extremely low birth weight infants (ELBWI) as those 
weighing less than 1000g.2 Most of the VLBWI are also preterm and therefore these terms 
are often used interchangeably. VLBWI being preterm are at risk of having fluid and 
electrolyte disturbances.  
 
Fluid management in preterm infants provides many challenges for the paediatrician and 
has long been a controversial topic.3–5 Much of the debate centres around the volume and 
type of fluid that is appropriate for a preterm infant in order to provide adequate nutrition 
but not to predispose the infant to complications of excessive fluid such as 
bronchopulmonary dysplasia, necrotising enterocolitis or patent ductus arteriosus.3  
Knowledge of fluid and electrolyte requirements, as well as renal function in premature 
infants is important in preventing morbidity and mortality associated with electrolyte 
disturbances.3–6  
 
1.1 Fluid compartments 
Fluid and electrolyte requirements for premature infants differ from those of term infants.7 
During early foetal life, 95% of the foetus’s body weight is water. As gestation increases, 
the proportion of total body water decreases, with the proportion being approximately 80% 
at 32 weeks gestation and 75% at term.4,6 This total body water (TBW) is distributed 
between three main compartments, namely: plasma, interstitial and intracellular 
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compartments.6 The plasma and interstitial compartments are collectively known as the 
extracellular fluid compartment which is primarily composed of sodium and water.8 
Newborns, especially those who are born preterm, have more extracellular fluid than 
intracellular fluid.4 In the postnatal period there is an acute reduction in the extracellular 
space.8 In the first week of life it is normal for healthy term neonates to lose up to 10%, 
and preterm infants  up to 15% of their body weight, and this is mostly all due to water 
loss.9  The diuresis that premature infants undergo post delivery is characterised by 
natriuresis despite having a low glomerular filtration rate (GFR).3,7  This normal 
contraction of the extracellular fluid space contributes to the effectively negative water and 
sodium balance experienced by premature infants during this adaptive phase. 8 
 
1.2 Renal factors affecting fluid balance in neonates 
There are multiple factors affecting fluid balance in the preterm infant, the first of which is 
renal function.10 Fluid and electrolyte balance is determined mostly by renal function.4 
Embryonic development of the kidney is a complex process with nephrogenesis starting at 
about 2-5 weeks gestation, maturation of the nephrons starting between 20-22 weeks 
gestation and completion of nephrogenesis by 34 weeks gestation. 5,10 Infants born before 
34 weeks gestation therefore have continuing formation of new nephrons post-delivery. 5 
The GFR is low in preterm infants due to the immaturity of the renal system and in 
combination with the immature nephrons that are present, means that they have a 
decreased ability to excrete excess fluid and/or electrolyte loads in the first few days of 
life.3,5 As gestational age increases so does renal function mature. 5 Premature infants have 
high urinary excretion rates of sodium when compared to term infants.7  As the GFR in 
premature infants is lower than term infants, the higher sodium excretion rates seen in 
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premature infants must be explained due to lower tubular reabsorption rate of sodium.7  
The proximal renal tubule reabsorbs most of the glomerular ultra filtrate.5 Sodium 
reabsorption in the proximal tubule is regulated by the sodium-potassium-ATPase pump on 
the luminal membrane.5 Due to immaturity of the proximal tubule, the proton pump has 
decreased activity in the neonatal tubule and therefore leads to decreased sodium 
reabsorption and ultimately also decreased reabsorption of water. 3  The prematurity of the 
renal tubular system means that a preterm infant has both a limited ability to excrete 
sodium and is also unable to retain sodium as effectively as term babies do. Post delivery 
tubular function rapidly matures as does the renal response to regulatory hormones, all of 
which are mechanisms for sodium homeostasis.3 However, the Renin-Angiotensin-
Aldosterone system (RAAS) in premature infants  cannot be appropriately inhibited which 
means that there is a high risk for sodium overload if high levels of sodium are given.3 
Also, the renal ability to both retain and excrete sodium load is reduced in the premature 
infant which makes them extremely vulnerable to adverse effects of inappropriate sodium 
administration in the first few days of life. 8 
  
Water homeostasis is regulated by either excretion of excess water or conserving it by 
concentrating the urine. However, in the premature infant the GFR is low which limits the 
delivery of fluid distally in the tubule.5  There is also a decreased ability to concentrate 
urine which in part is due to the blunted  response of the collecting duct to antidiuretic 
hormone (ADH) . 5 Premature infants therefore have higher fluid losses due to increased 
IWL which is further compounded by renal factors which hinder reabsorption of water, all 
of which predispose the neonate to dehydration. 3,8 
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1.3 Insensible water losses 
Another factor contributing to fluid balance is water loss. Water loss in newborns can be 
due to sensible losses, which are quantifiable (e.g. urine losses, faecal water losses) or 
insensible losses which are not quantifiable (e.g. water loss through skin or respiration).4  
Sensible losses should make up the majority of loss, but premature and particularly 
VLBWI, have high insensible water losses (IWL) which  can be as high as 200ml/kg/day 
in some instances.10–12 Insensible water loss also varies with gestational age - the lower the 
gestational age the higher the IWL.13 VLBWI have disproportionately higher 
transepidermal water losses (TEWL), as they have a relatively large body surface area to 
weight ratio and their skin is immature as it has an immature stratum corneum and  lacks 
keratin. Keratinisation starts at around 18 weeks gestation but it is not until 34 weeks 
gestation that the stratum corneum becomes well developed.8 Unlike renal function, skin 
maturation is not accelerated by the administration of antenatal steroids, it is accelerated by 
birth and increasing postnatal age.8 The immaturity of the preterm infants skin lead to 
increased water  losses via evaporation and convection, which  can be precipitated by 
numerous environmental factors 1,4,6,10,14  Infants younger than 36 weeks gestation cannot 
sweat - for this reason only water  and no sodium is lost through the skin.8  
 
Environmental factors that contribute to increased IWL in VLBW premature infants are: 
nursing infants under radiant warmers, receiving phototherapy or being ventilated  with 
non- humidified oxygen.6 The highest levels of TEWL occurs in the first few days post-
delivery, and those infants less than 28 weeks gestation who are nursed under radiant 
warmers are the most vulnerable to increased losses.8  Water is lost from the skin through 
convection and conduction and when water evaporates from the skin it is accompanied by 
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the loss of heat.13,15  A high humidity environment can decrease TEWL, and this can be 
provided by double walled incubators.8  Several research papers have suggested that 
radiant warmers affect IWL more so than incubators, however more recent studies have 
shown that the TEWL does not differ markedly between non-humidified incubators and 
radiant warmers.15  Due to prematurity, these infants are also frequently tachypnoeic or are 
in respiratory distress which may require ventilation (e.g. nasal continuous positive airway 
pressure or conventional mechanical ventilation). Tachypnoea in itself increases insensible 
water loss.1,4,6  Current evidence is conflicting as to whether or not modern phototherapy 
units increase TEWL.3,8  Most paediatricians will increase daily fluid intake by 
20ml/kg/day and in an otherwise healthy infant this extra fluid is unlikely to cause any 
harm.3 
 
Aside from increased water losses in premature infants, it should also be recognised that 
when compared to term infants, VLBWI have increased fluid requirements as well. This is 
due to the fact that they have a higher metabolic rate which means they have a higher 
caloric expenditure and ultimately need higher fluid intake to meet this demand.4,6 
Therefore it is often not possible to provide adequate fluid amounts that avoid electrolyte 
abnormalities or fluid deficit.  
 
1.4 Incidence of hypernatraemia 
Hypernatraemia is a common derangement encountered in the management of VLBWI 
infants.10,11 Literature varies with regards the definition of hypernatraemia with some 
defining it as a serum sodium of > 147mmol/L and others as >150mmol/L.16–18 It is most 
commonly encountered in the first 72 hours of life.10 The incidence of hypernatraemia in 
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VLBWI is not well documented. Harkavy and Scanlon reported the incidence of 
hypernatraemia in preterm infants as 40% while Gawlowski et al reports the incidence as 
30%. 10 
 
1.5 Causes of hypernatraemia 
In neonates hypernatraemia is most often due to excessive fluid loss or decreased fluid 
intake, rather than excess sodium intake.10,11 Neonates are solely reliant on caregivers for 
provision of fluid maintenance and caloric requirements, and it is therefore of vital 
importance to have a thorough knowledge of the fluids administered to these infants. 
Within any neonatal unit, protocols are in place regarding fluid management, which 
ensures consistency in the management of VLBWI.  An intravenous fluid prescription 
should take into account water losses through urine plus the estimated insensible water loss 
of the patient.8 Starting a patient on a 10% glucose solution is acceptable, but it is 
suggested that sodium intake should only start once there has been weight loss of 
approximately 6% of the birth weight.8 Randomised trials have suggested that early 
administration of sodium increases the risk of hypernatraemia as well as the risks of 
respiratory morbidity by hampering the normal contraction of the extracellular fluid space.8  
 
Monitoring adequate fluid administration should be undertaken carefully, and this is done 
by recording birth weight and subsequent weight loss, serum creatinine, sodium and 
potassium levels as well as measuring urine output from birth.8 Often overlooked, but also 
important, is that these neonates get inadvertent sodium loads while admitted, which could 
contribute to the development of hypernatraemia (e.g. drug administration such as 
dopamine or dobutamine or from flushing intravenous lines).6 Daily sodium requirements 
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are 2-3mmol/kg/day and should not be exceeded.4 There are two basic defence 
mechanisms against developing hypernatraemia namely, the ability to produce 
concentrated urine and the development of  thirst.19 The premature infant however, has an 
impaired ability to concentrate their urine and are unable to provide for themselves even if 
thirsty.4 
 
1.6 Morbidity and mortality associated with hypernatraemia 
The morbidity and mortality associated with hypernatraemia is mostly due to dehydration 
and the subsequent fluid and electrolyte shifts between compartments. 20 Hypernatraemia 
leads to an efflux of fluid from the intracellular space into the extracellular space to 
maintain osmotic balance.19,21 This shift subsequently leads to temporary cerebral 
dehydration and cell shrinkage.19,21  Within an hour, the brain compensates by increasing its 
intracellular content of sodium, potassium and idiogenic osmoles.19,21  Within a week the 
brain would have regained 95% of its water content.19 If hypernatraemia develops quickly 
however, the brain may be unable to increase its intracellular solutes sufficiently to 
maintain its volume.19,21 The immature brain is fragile and cerebral dehydration from 
hypernatraemia can lead to physical separation of the brain from the meninges, which leads 
to rupture of delicate bridging veins and results in intracranial and intracerebral 
haemorrhages, venous sinus thrombosis and infarction.19,21 These complications can 
ultimately lead to severe brain damage, adverse neurodevelopmental outcomes and 
death.10,12 Intracerebral haemorrhages may lead to destruction of hypothalamic nuclei 
which decreases the secretion of ADH, limiting water reabsorption by the kidney and 
therefore perpetuating the hypernatraemia. 21  
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1.7 Management of hypernatraemia 
The goal of management of hypernatraemia in preterm infants is to reduce sodium levels 
by correcting fluid deficit and avoidance of giving extra sodium.21 The amount of fluid 
given to correct hypernatraemia depends on its severity and the rate at which the 
hypernatraemia is corrected. The brain has a relative inability to excrete idiogenic osmoles 
and therefore too rapid  a correction of the hypernatraemia can lead to cerebral oedema and 
associated seizures.19,21 It is generally accepted that the rate of correction should be a 
reduction of serum sodium levels of 0.5mmol per hour or 12 mmol in 24 hours.19,21  
 
Correcting the free water deficit is done by calculating the amount of free water needed to 
reduce the sodium level by 0.5mmol/hour.17  In the case of severely elevated sodium levels 
it is apparent that the sodium level may not return to normal values within 24 hours, but it 
should be understood that the goal of management is to return the level to normal values at 
a safe rate, not necessarily within a given time. One of the formulas that have been used to 
calculate amount of extra water to be given to correct hypernatraemia is as follows: 
millilitres of free water over 24 hours = 600 x weight (kg) x (1-required sodium/current 
sodium). 22 
 
Required sodium would be the serum sodium level you want to achieve over the 24 hour 
period. Free water fluids are added over and above the usual maintenance requirements of 
the infant. If daily sodium requirements are already being met by maintenance fluids, a 
sodium free fluid such as 5% dextrose water is added to correct the hypernatraemia. 
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1.8 Justification for study 
Chris Hani Baragwanath Academic Hospital (CHBAH) provides healthcare services to a 
large neonatal population, both born at the hospital or referred from surrounding clinics.  It 
is estimated that about 3-5% of deliveries are VLBWI. The proportion of VLBWI who 
develop hypernatraemia at CHBAH is not known. It is important to know the incidence of 
hypernatraemia as it is associated with high morbidity and mortality. Information on how 
these patients are managed will assist in whether to review the current practice on fluid 
management or not, as changes in fluid management might affect outcomes. Secondly the 
fluid used for maintenance requirements on day one of life contains sodium, while the 
recommendation is not to provide sodium to newborn babies on the first day of life. 
Clinicians managing these infants are often trainees who might under- or overestimate 
fluid requirements leading to electrolyte disturbances. Underestimation of fluid 
requirements might result in hypernatraemia. This study would therefore like to determine 
the incidence of hypernatraemia in VLBWI admitted in CHBAH neonatal  unit, as well as 
document  the fluid management  and outcome of VLBWI with hypernatraemia.  
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2.0  STUDY AIMS 
The aims of the study were to determine the incidence, fluid management and mortality 
rate in infants with hypernatraemia and factors associated with its severity. 
The objectives of this study were: 
• To determine the proportion of VLBWI who develop hypernatraemia (serum 
sodium ≥150 mmol/ L ) in the first 72 hours of life  in the Neonatal Division at 
CHBAH 
• To determine the amount and type of fluids that the hypernatraemic VLBWI were 
receiving at time of  diagnosis of hypernatraemia 
• To determine the amount and type of fluid that  the infant was receiving when  
hypernatraemia resolved 
• To determine the time it takes for hypernatraemia to  be corrected 
• To document mortality rate in infants with hypernatraemia  
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3.0  METHODOLOGY 
3.1 Research question 
What is the incidence, fluid management and mortality rate of hypernatraemia in very low 
birth weight infants born and/or admitted at Chris Hani Baragwanath Academic Hospital? 
 
3.2 Study design 
This was a retrospective descriptive study.  
 
3.3 Study site and population 
The study was based at the Neonatal Division of Paediatrics at Chris Hani Baragwanath 
Academic Hospital. All VLBWI born at <37 weeks gestation, who were admitted at 
CHBAH between 1 June and 31 December 2012, and were diagnosed with hypernatraemia 
within 72 hours of life were eligible for the study. Very low birth weight infants were 
defined as infants who were born weighing less than 1500g. Hypernatraemia was defined 
as serum sodium greater than 150 mmol/L 
 
3.4 Data collection 
The medical records of VLBWI with a diagnosis of hypernatraemia were reviewed. Data 
on maternal demographics, infant characteristics, serum sodium levels, type and amount of 
fluids infants received at diagnosis and in response to hypernatraemia, as well as the 
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number of patients who died within the first 28 days of life was collected and recorded in 
an appropriately designed data collection sheet.  (Appendix A) 
 
3.4.1 Maternal demographics 
Maternal details were collected from the infant hospital file, as they are recorded on the 
front page of the file at admission in the form of text or check boxes. Where a check box 
was not ticked next to a treatment or diagnosis in the mother, it was assumed that the 
mother did not have the treatment or diagnosis. The following maternal details were 
collected; maternal age, whether antenatal care was received, gravidity, place and mode of 
delivery, maternal illness during pregnancy or labour, HIV status and whether antenatal 
steroids were given or not. 
 
3.4.2 Infant characteristics, diagnosis and outcome  
The data included for these infants were  birth weight, gestational age, Apgars at 1 and 5 
minutes post-delivery, gender, date, time of birth, diagnosis of intraventricular 
haemorrhage and mortality at 72 hours, and 28 days of life.  Gestational ages were 
obtained from obstetric notes in the form of dates of last menstrual period or from early 
ultrasound, and in addition all premature babies have their gestational age clinically 
determined using a Ballard score. The neonates are given gestational age based on sonar if 
the sonar was done during the first semester and where this is not available, a gestational 
age  from the Ballard score is used.  
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3.4.3 Environmental factors 
Information regarding the infants nursing environment was collected. The information 
retrieved was related to the environment in which the infant was nursed in the first 72 
hours of life. The use of incubator versus (vs.) radiant warmer, need for ventilation in the 
form of  nasal continuous positive airway pressure (nCPAP), conventional mechanical 
ventilation (CMV) or both as well as the use of phototherapy was recorded. 
 
3.4.4 Type and amount of fluids administered  
The type and volume of fluid (ml/kg/day) received by the infant was collected at three time 
points; at birth, at time of diagnosis of hypernatraemia, and in response to hypernatraemia. 
The volume received per day included both oral and intravenous fluids.  When fluids were 
adjusted in order to correct the hypernatraemia, it was assessed whether or not the 
additional fluid was calculated according to the formula, [600 x weight(kg) x {1- desired 
sodium/serum sodium] or not.  Where calculation of fluid adjustment for hypernatraemia 
was not recorded in patient files, the researcher calculated fluid adjustments to determine 
whether the formula was used or not. The amount of sodium received by each neonate at 
birth from their prescribed fluids was calculated (mmol/kg/day) and was stratified in to the 
following groups; <2.5mmol/kg/day, 2.5-2.99mmol/kg/day and ≥3mmol/kg/day. 
 
In an attempt to determine the amount of fluids administered in response to  
hypernatraemia, I determined the amount of fluids the patient was on when the bloods 
showing hypernatraemia were done, and amount of fluids the patient was put on after 
hypernatraemia was diagnosed.   
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3.4.5 Diagnosis of hypernatraemia  
Blood results with serum sodium were captured from the patients’ files. The specimen 
reference numbers were used to check the times that specimens were received at the 
laboratory.  In order to determine the time it took for hypernatraemia to resolve serum 
sodium levels were recorded from the first sodium recorded to be >150 mmol/L and all 
subsequent ones until the serum sodium was <150 mmol/L or patient died.  
 
3.5 Ethical clearance 
3.5.1 Permission 
Permission to perform the study was obtained from the Human Research Ethics Committee 
of the University of the Witwatersrand (Clearance number M130652) and from the 
Protocol Review Committee of the CHBAH (appendix C). 
 
 
3.5.2 Confidentiality 
A list which contained the names and hospital numbers of the selected infants was kept 
confidential by the author. This list was used only during retrieval of the medical records. 
Entry of data on the collection data sheets and on the computer spreadsheet was coded and 
anonymous. 
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3.6 Data processing and statistical analysis 
Each patient was allocated a study number. Study data were collected and managed using 
REDCap (Research Electronic Data Capture) electronic data capture tools hosted at the 
University of the Witwatersrand. REDCap  is a secure, web-based application designed to 
support data capture for research studies.23  Means and standard deviations were used to 
describe continuous variables with normal distribution. Where continuous variables were 
not normally distributed, median and ranges were used. Frequencies and percentages were 
calculated for categorical variables. Comparisons were done using Pearson Chi-square test 
for categorical variables and Student t-test or One Way Analysis of Variants (ANOVA) for 
continuous variables. All statistical tests were carried out in STATISTICA Version 12 
and/or SPSS version 20.  
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4.0  RESULTS 
Four hundred and forty three VLBWI were delivered at CHBAH, between 1 June 2012 and 
31 December 2012. Files for 370 VLBWI, born during this period, were retrieved, 
reflecting an 83.5% recovery rate of files. One hundred and thirty five patients with 
hypernatraemia were identified but in 10 patients the hypernatraemia was diagnosed after 
72 hours of life and were therefore excluded. A further 5 patients were excluded from 
statistical analysis as the details regarding fluid management were missing from the files.  
These five patients were however used in the calculation of incidence as they met the 
inclusion criteria, but not in further analysis of the data. In summary 125 patients were 
included to calculate the incidence but only 120 were included for further analysis.  
 
4.1 Incidence   
Among the 370 files retrieved, 125 infants were identified to have hypernatraemia. Of the 
125 VLBWI,  30 (24%) had a birth weight of <1000g (ELBWI) and 95 (76%) had birth 
weights between 1000g - 1499g.  The overall incidence of hypernatraemia in this cohort of 
VLBWI was 33.8% (Figure 4.1). 
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Figure 4.1 Incidence of hypernatraemia in VLBWI  at CHBAH  
 
4.2 Maternal demographics 
Characteristics of mothers who gave birth to VLBWI with hypernatraemia are illustrated in 
Table 4.1. The average maternal age was 27 years. The majority of mothers (86.6%) 
attended antenatal care and were negative for human immunodeficiency virus (72.5%). 
Majority of mothers (71.7%)  had no recorded illness in the antenatal period and  25.8% 
had a diagnosis of  hypertension and/ or HELLP syndrome.  Antenatal steroids were only 
administered to 30% of mothers of VLBWI.  
  
No. of VLBW born June - Dec 2012 
n=443 
Files retrieved from records 
n=370 (83.5%) 
Hypernatraemia  identified in first 72hrs of life  
n = 125 
Birth Wt < 1000g 
n = 30 (24%) 
Birth Wt  1000g - 1499g 
n = 95 (76%) 
Overall incidence of hypernatraemia in VLBW 
infants  
125/370 (33.8%) 
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Table 4.1  Maternal characteristics of VLBWI with hypernatraemia 
Characteristics Number (%) 
Maternal Age 26.87 ± 6.58* 
Antenatal Care 
Yes 
No 
 
104 (86.6) 
  16 (13.3) 
Place of Birth 
CHBAH 
Clinic 
Home 
 
108 (90.0) 
    8 (6.67) 
    4 (3.33) 
Mode of Delivery 
Vaginal 
Caesarean section 
Unknown 
 
47 (39.2) 
72 (60.0) 
  1 (0.83) 
Gravida 
   1 
1 - 3 
> 3 
unknown 
 
41 (34.2) 
55 (45.8) 
17 (14.2) 
  7 (5.83) 
Maternal Illness 
None 
Hypertensive disorders 
Other 
 
86 (71.7) 
31 (25.8) 
  3 (2.50) 
HIV 
Positive 
Negative 
Unknown 
 
32 (26.7) 
87 (72.5) 
  1 (0.83) 
Antenatal Steroids 
Yes 
No 
 
36 (30.0) 
84 (70.0) 
*- values given as means± standard deviation 
 
4.3 Infant characteristics 
The infant characteristics are summarised in Table 4.2. Almost all VLBWI admitted into 
the Neonatal Division were delivered at CHBAH (90%) and the majority were delivered 
through caesarean section (60%). The distribution of VLBWI across gender was fairly 
similar with 49.2% being male and 50.8% being female. The mean gestational age was 29 
weeks with the majority (69%) falling between 26-30 weeks gestational age. Majority 
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(75.8%) of VLBWI had a birth weight between 1000g and 1499g. Just over 50% of infants 
had an Apgar score <7 at 1 minute compared to 22% at 5 minutes.  
 
Table 4.2 Characteristics of VLBWI with hypernatraemia 
Characteristics Number (%) 
Gender 
Male 
Female 
 
59 (49.2) 
61 (50.8) 
Gestational Age (weeks) 
<26  
26 - 28 
29 - 30 
31 - 34 
> 34 
29.3 ± 2.5* 
  4 (3.30) 
48 (40.0) 
35 (29.2) 
31 (25.8) 
  2 (1.66) 
Birth Weight 
<1000 grams 
1000 – 1499 grams 
 
29 (24.2) 
91 (75.8) 
Apgar 1 min 
<4 
4-6 
7-10 
Apgar 5 min 
<4 
4-6 
7-10 
 
19 (17.0) 
40 (35.7) 
61 (54.5) 
 
12 (10.7) 
13 (11.6) 
95 (84.8) 
*values given as means ± standard deviation   
 
4.3.1 Serum sodium levels in infants with  hypernatraemia according to birth 
weight and gestational age 
The median sodium level at diagnosis of hypernatraemia in those VLBWI with a weight of 
<1000g was 153mmol/L (range 150 - 159mmol/L) and in those with a birth weight 
between 1000-1499g the median was 152mmol/L ( range  150 - 197mmol/L) (Figure 4.2). 
There were no statistical significant differences in levels of serum sodium at diagnosis of 
hypernatraemia between the two weight categories (p=0.26). Using a one way ANOVA to 
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compare the serum sodium amongst the different gestational age groups also did not show 
statistical significant differences (p=0.31) (Figure 4.3). The median serum sodium levels 
were 152mmol/L (range 150-197), 153mmol/L (range 150-157) and 153mmol/L (range 
150-182), for infants receiving sodium of <2.5, 2.5-2.99 and ≥3.0mmol/kg/day respectively 
(Figure 4.4). A one-way ANOVA showed no statistical difference in the level of 
hypernatraemia between the three groups (p=0.58), suggesting that the differences in 
amounts of sodium the infants were receiving at diagnosis did not impact on the severity of 
the hypernatraemia.    
 
 
Figure 4.2  Serum sodium across the different weight categories at time of diagnosis 
n  = 29 n  = 91 
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Figure 4.3 Serum sodium levels across gestational ages at time of diagnosis  
 
n  = 4 n  = 48 
n  = 35 
n  = 23 
n  = 10 
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Figure 4.4 Serum sodium levels in relation to amount of sodium the infants were receiving 
at diagnosis 
  
n  = 70 n  = 32 n  = 18 
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4.3.2 Total fluid management prescribed at birth (ml/kg/day) 
The majority of infants were kept nil per mouth on day one of life and received their fluids 
intravenously. The fluid prescribed at birth was Potassium-free Neonatalyte, which 
contains 33 mmols of sodium per litre. The median amount of fluid prescribed across the 
two weight groups was 80ml/kg/day with the ranges being between 60 - 110ml/kg/day 
(Table 4.3). With regards the gestational age groups, all groups had a median fluid volume 
of 80ml/kg/day except for those VLBWI with gestational ages of <26 weeks, whose 
median was 87.5ml/kg/day of fluid. 
 
Table 4.3 Total amount of fluids infants were receiving at time of admission stratified 
according to birth weight and gestational age (ml/kg/day) 
 
Volume  (Median) 
ml/kg/day 
Volume (Ranges) 
ml/kg/day 
Birth Weight 
< 1000g (n=29) 
1000g - 1499g (n=91) 
 
80 
80 
 
75 - 100 
60 - 110 
Gestational Age 
<26 wks (n=4) 
26 - 28 wks (n=48) 
29 - 30 wks (n=35) 
31 -34 wks (n=31) 
> 34 wks (n=2) 
 
87 
80 
80 
80 
80 
 
80 - 100 
70 -100 
70 - 100 
60 - 110 
80 - 80 
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4.3.3 Prescribed fluids at time of diagnosis of hypernatraemia  
At time of diagnosis of hypernatraemia the ranges of fluid across all birth weight and all 
gestational ages were between 80 - 167 ml/kg/day (Table 4.4).  
 
Table 4.4 Total amount of fluids the infants were receiving at time of diagnosis of 
hypernatraemia 
 
Median Volume 
(ml/kg/day) 
Ranges 
(ml/kg/day) 
Birth Weight 
< 1000g (n=29) 
1000g - 1499g (n=91) 
 
120 
105 
 
80 - 160 
80 - 167 
Gestational Age 
<26 wks (n=4) 
26 - 28 wks (n=48) 
29 - 30 wks (n=35) 
31 -34 wks (n=31) 
> 34 wks (n=2) 
 
125 
120 
110 
100 
94 
 
80 - 130 
80 - 162 
80 - 160 
85 - 167 
88 - 100 
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4.3.4 Fluid management in response to hypernatraemia 
The diagnosis of hypernatraemia was made within the first 72 hours of life with two 
infants being diagnosed on day 1 of life, 72 on day two of life and 46 on day three of life.  
Fluids are adjusted based on the level of hypernatraemia. Most of these patients had serum 
sodium levels between 150-154mmol/L (n=84) with only seven patients having high levels 
of between 165-170mmol/L.  In the first group, the median total fluids were 114ml/kg/day, 
with a range of 80-167ml/kg/day (Table 4.5). Fluids were increased by an average of 
45ml/kg (range: 0-100ml/kg). In the latter group, the median fluid at time of diagnosis was 
120 ml/kg/day with an increase in fluids by 90ml/kg (range: 0-170ml/kg). It can be seen 
that the higher the sodium level, the more fluid was added to the already existing fluid 
prescription.  
 
Table 4.5 Adjustments made in fluid volume (median and ranges) in response to 
hypernatraemia 
Serum Sodium No. Total fluids at diagnosis (ml/kg/d)  
Total fluids after 
diagnosis 
(ml/kg/d) 
Amount fluids 
increased by (ml/kg) 
150-154 mmol/L 84 114  (80-167) 160 (85-222) 45 (0-100) 
155-159 mmol/L 23 107 (80-162) 165 (103-255) 55 (0-75) 
160-164 mmol/L 6 104 (85-160) 180 (133-209) 70 (48-92) 
165-170 mmol/L 7 120 (100-120) 190 (100-290) 90 (0-170) 
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The fluid administered for correction of hypernatraemia in 99 patients was 5% dextrose 
water, and of these, 79 patients had the volume increase calculated according to the 
formula previously mentioned whereas 20 did not (Table 4.6). Of the remaining patients 
who did not have their additional fluid volumes calculated according to the formula 
(n=27), 4 were prescribed Potassium-free Neonatalyte and 3 were given Neonatalyte. 
Fourteen patients had no adjustments made to their fluids. 
 
Table 4.6 Distribution of patients who had fluids increased according to method used to 
calculate volume and type of fluid used to correct hypernatraemia (n=106*/120) 
 
Type of fluid used to correct in 
addition to Maintenance fluid 
Number of Patients 
with volume increase 
calculated according 
to formula 
n (%) 
Number of Patients 
with volume 
increase not 
according to 
formula 
n (%) 
All patients who 
were started on 
fluids to correct 
hypernatraemia 
Fluid with no sodium 
(Dextrose water) 79 (78) 20 (22) 99 
Fluid with sodium, 33 mmol/L 
(Potassium free Neonatalyte) 0  4 (100) 4 
Fluid with sodium, 20 mmol/L 
(Neonatalyte) 0  3 (100) 3 
Any fluid used 79 (75) 27 (25) 106 
*-Fluids not adjusted in 14 infants 
The average time taken for the hypernatraemia to resolve was 44.1 hours. Those infants 
whose fluids were calculated according to the formula resolved within 43.6 hours and 
those where the formula was not used resolved in 45.1 hours (Table 4.7).  A Pearson chi-
squared test showed no statistical difference in the time to resolution between the two 
groups (p=0.57). Fourteen  of the infants never had any adjustments made to their 
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prescribed fluids when the hypernatraemia was diagnosed, one patient had no repeat blood 
specimens taken therefore couldn't be included in rate calculations and 6 patients died prior 
to resolution. 
 
Table 4.7 Rate of correction (hours) of hypernatraemia according to method used to 
calculate fluid volume (n=99*/120) 
Hours (h) to resolution 
Formula 
n (%) 
No Formula 
n (%) 
Total 
n (%) 
< 24 h 3  (4.11) 0  (0.00) 3  (3.03) 
24-48 h 31  (42.4) 12 (46.1) 43  (43.4) 
49-72 h 25  (34.2) 9  (34.6) 34  (34.4) 
73 – 96 h 10  (13.7) 3  (11.5) 13  (13.1) 
> 96 h 4  (5.48) 2  (7.69) 6   (6.06) 
Average  hours to 
resolution 43.6 ± 25.92 45.1 ± 36.24 44.1 ± 28.80 
*Fluids not adjusted in 14 patients, 6 patients died prior to resolution and 1 patient had no repeat bloods 
taken and was not included in rate calculations 
 
Rate to correction was also calculated in mmol per hour decrease in the sodium level. The 
time that the specimen was received at the lab as well as time the specimen was received 
once hypernatraemia resolved was used to extrapolate the mmol/hour rate of sodium 
decrease. Thirteen patients could not be included in calculating the rate of decrease of the 
serum sodium as there were no recorded times for specimens received or only had one 
blood result. The average rate of correction when the formula was used was 
0.28mmol/hour, when no formula was used it was 0.57mmol/hour, and with no fluid added 
it was 0.39mmol/hour (Table 4.8, Figure 4.5). The average times for correction was 
therefore slower than recommended in the formula group and within recommended time 
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for the non formula users. However, a Pearson chi-square test showed no statistical 
significance in the rate of resolution of the hypernatraemia in mmol/hour between the 
groups. (p= 0.22). 
 
Table 4.8 Rate of correction (mmol/hour) of hypernatraemia according to method used to 
calculate fluid volume (n=107* /120) 
Rate of correction of 
hypernatraemia (mmol/ hr) 
Formula 
n (%) 
No Formula 
n (%) 
Fluid not adjusted 
n (%) 
Total 
< 0.5 58 (80.6) 20 (86.9) 9 (75.0) 87 (81.3) 
0.5 - 1  10 (13.9) 0 (0.00) 1 (8.33) 11 (10.3) 
≥ 1 4 (5.56) 3 (13.0) 2 (16.7)   9    (8.41) 
Average rate of correction 0.28 ± 0.28 0.57 ± 0.58 0.39 ± 0.42 0.41 ± 0.43 
*- Rate of correction not calculated for infants who demised with only a single blood result 
being taken (n=4), infants who didn't have times that specimens were received at the lab 
recorded (n=8) and the infant who did not have repeat results (n=1) 
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Figure 4.5 Rate of correction of hypernatraemia (mmol/hour) according to method used to 
calculate fluid volume increases 
 
4.4 Environmental factors 
Just over half of infants (55.8%) were nursed in an incubator while the rest were nursed 
under a radiant warmer (Table 4.9). The mean sodium level in those infants nursed in an 
incubator was 153.8 mmol/L, and in those under radiant warmer it was 155.5mmol/L. 
There was no statistical significant difference in the severity of  hypernatraemia between 
these two environmental factors (p=0.16).  
n = 72 
n = 23 
n = 12 
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There were 66 infants who were started on phototherapy for jaundice in the first 72 hours 
of life - 35 were nursed in an incubator and 31 under radiant warmer while receiving the 
phototherapy.  There were also no statistical significant differences in the levels of serum 
sodium in those infants receiving phototherapy  whether they were nursed in an incubator 
or nursed in a radiant warmer (p=0.31). 
 
Table 4.9 Environment under which infants were nursed at time of diagnosis of 
hypernatraemia and serum sodium levels 
 n (%) 
Serum Sodium 
(mean ±SD) 
Incubator 
With Phototherapy 
Without Phototherapy 
 
35 (52.2) 
32 (47.8) 
 
153.6 ± 4.52 
153.9 ± 5.92 
Radiant warmer 
With Phototherapy 
Without Phototherapy 
 
31 (58.5) 
22 (41.5) 
 
155.4 ± 9.06 
155.8 ± 8.06 
 
The mean number of hours to resolution of hypernatraemia when nursed in an incubator 
was 49.7 hours  vs. 37.7 hours when nursed under a radiant warmer (Table 4.10). The 
resolution of hypernatraemia was significantly faster when patients were nursed under a 
radiant warmer (p = 0.037). There was no statistical difference between the total fluid 
volume infants were receiving (p=0.85) or in the severity of hypernatraemia (p=0.16) 
between those infants nursed in an incubator and those nursed in a radiant warmer, which 
could have accounted for the difference in time to resolution  
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Those patients who received phototherapy took 47.0 hours for their sodium levels to return 
to normal, whereas those that did not receive phototherapy resolved in 41.1 hours and this 
difference was statistically significant (p= 0.031) ( Table 4.10)  
 
Table 4.10 Effect of radiant warmer or incubator on time to resolution of hypernatraemia 
 
Hours to resolution 
Mean ± Std Dev 
Incubator 49.7 ± 33.4 
Radiant Warmer 37.7 ± 20.2 
Received phototherapy 47.0 ± 34.1 
No phototherapy 41.0 ± 20.6 
 
4.5 Morbidity associated with hypernatraemia with a focus on 
occurrence of intraventricular haemorrhage  
Cranial ultrasounds were done on 47 of the VLBWI with hypernatraemia. Of these, 31 
infants had no IVH, three had Grade 1, six had Grade 2 and seven had Grade 3 IVH. 
(Table 4.11)  
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Table 4.11 Finding of IVH in patients with hypernatraemia who had cranial ultrasound 
done 
 Number Percent 
No IVH 31 64.6 
Grade 1 3 6.25 
Grade 2 6 14.5 
Grade 3 7 14.6 
Grade 4 0 0.00 
 
4.6 Outcomes within the first 28 days of life 
The all-cause overall mortality rate by 28 days of life amongst VLBWI who had been 
diagnosed with hypernatraemia was 22.5% (n=27). Of these, five died within the first 72 
hours, 10 died between 72 hours and less than 7 days and 12 died between 7 and 28 days.  
Of note is that six patients demised before the hypernatraemia was corrected - five of them  
having had their fluid deficit calculated according to the formula.  Three of the patients 
who died before correction had a sodium level at diagnosis of 151mmol/L, while the 
remaining three had levels of 150mmol/L, 155mmol/L and 157mmol/L. The causes of 
death were related to sepsis in three of these patients, nosocomial sepsis in two and type 
two respiratory failure in one. 
 
The VLBWI infants who died were of smaller weight (p<0.001) and lesser gestational age 
(p<0.001) compared to those who survived, but there were no significant differences in 
serum sodium levels at diagnosis (p = 0.070) (Table 4.12). 
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Table 4.12  Comparison between survivors and non-survivors 
 Survivors 
Median (ranges) 
Non-survivors 
Median (ranges) 
ANOVA 
p-value 
Birth Weight (grams) 1190 (810 - 1490) 970 (800 - 1355) < 0.001 
Gestational Age 
(weeks) 29 (25 - 38) 28 (23 -31) < 0.001 
Serum Sodium at 
diagnosis (mmol/L) 152 (150 - 182) 154 (150 - 197) 0.07 
 
The postnatal age at which they died was not associated with birth weight (p=0.430), 
gestational age (p=0.710) or serum sodium levels (p=0.360) at diagnosis (Table 4.13). 
 
Table 4.13 Comparisons among the non-survivors according to postnatal age at time of 
death 
 Demised at 
< 72hrs 
Median (ranges) 
Demised at 
72hrs - 7 days 
Median (ranges) 
Demised at 
7 - 28 days 
Median (ranges) 
ANOVA 
p-value 
Birth Weight (grams) 820 (800 - 1355) 973 (865 - 1295) 1005 (890 - 1355) 0.43 
Gestational Age 
(weeks) 27 (25 - 29) 29 (24 - 31) 28 (23 - 31) 0.71 
Serum sodium  at 
diagnosis (mmol/L) 152 (150 -155) 154 (150 - 197) 154 (151 -178) 0.36 
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5.0  DISCUSSION  
Very low birth weight infants (VLBWI) are at high risk for fluid and electrolyte 
disturbances, including hypernatraemia, due to the prematurity of multiple systems that 
allow for increased IWL.10–12  Hypernatraemia is an electrolyte abnormality with a reported 
incidence of  30-40%  in  VLBWI, usually occurring within the first 72 hours of life, and is 
associated with high morbidity and mortality in these infants.10  It is most commonly 
caused by excessive fluid loss or decreased fluid intake, rather than increased sodium 
intake, highlighting the importance of fluid management in the first few days of life.10,11,16,21  
A number of environmental factors namely incubators, radiant warmers and phototherapy 
may worsen this water loss during the first 72 hours of life.1,4,6  Hypernatraemia alone or 
the management thereof is associated with certain morbidities and mortality, therefore its 
management is critical in survival of preterm infants with or without morbidities. In this 
report I assessed the incidence of hypernatraemia, fluid management and outcomes from a 
neonatal unit with a large number of VLBWI.  
 
The findings from this study are that the incidence of hypernatraemia in VLBWI admitted 
at CHBAH is very high at 33.8%.  The majority of VLBWI who developed hypernatraemia 
were of gestational age less than 30 weeks. Only 30% of infants received antenatal 
steroids. All infants were started on a sodium containing fluid (Potassium-free Neonatalyte 
containing 33 mmol/L of sodium). The volume of fluids infants were started on at birth in 
ml/kg/day were almost similar for all weight categories and gestational ages. At time of 
diagnosis the severity of hypernatraemia was not related to gestational age, birth weight or 
to the amount of fluid or sodium that the infant was receiving. In the majority of patients 
the amount of fluid used to correct hypernatraemia was calculated based on a formula for 
free water-deficit. The method used to determine amount of fluids did not affect rate of 
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correction of hypernatraemia. The rate of correction of hypernatraemia was appropriate in 
the majority of cases, as only 8.4% had their sodium levels reducing by >1 mmol/hour. The 
environment under which infants were nursed did not affect the severity of 
hypernatraemia. Among the infants who had cranial ultrasounds done and results recorded, 
15% had grade III IVH. The all-cause overall mortality rate in  infants with hypernatraemia 
during the neonatal period was 22%, and  the proportion of infants who died was greater in 
infants with smaller birth weight and younger gestational age.  
 
Previous studies have shown that insensible water losses are higher the more premature an 
infant is, and therefore the higher the risk of hypernatraemia.1,3,10 The severity of the 
hypernatraemia in this study was not affected by birth weight or gestational age. The lack 
of association between severity of hypernatraemia and birth weight in this study, could be 
explained by the fact that ELBWI were of higher gestational ages, or had more intensive 
management in order to limit IWL,  such as the use of plastic covers in the unit for 
example.  
 
The high incidence of hypernatraemia in this cohort could be related to the use of sodium 
containing fluids on admission. It is suggested that sodium intake should only start once 
there has been loss of approximately 6% of the birth weight.8 Randomised trials have 
suggested that early administration of sodium increases the risk of hypernatraemia as well 
as the risks of respiratory morbidity by hampering the normal contraction of the 
extracellular fluid space.8 There is a need for a prospective randomised control trial with 
infants being allocated to either a sodium free solution (10% dextrose) or Potassium-free 
Neonatalyte.  
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Once hypernatraemia was diagnosed, the majority of patients were managed with an 
increase in fluid volume with either a sodium-containing or sodium-free solution. The fact 
that the hypernatraemia resolved by adding free water alone, without restricting sodium 
intake support findings from previous studies that hypernatraemia in preterm or VLBWI is 
almost always due to increased insensible water losses.6,10,11   Correcting hypernatraemia 
using sodium containing fluids may increase the sodium delivery more than the daily 
recommended amount and therefore delay resolution of hypernatraemia. Thus using a 
sodium-free solution like 5% dextrose water to correct water deficit that resulted in 
hypernatraemia appears to be appropriate. A formula that calculates water deficit to correct 
hypernatraemia has been suggested, and this formula was used in this study and appeared 
to be safe. 22  
 
Both phototherapy and radiant warmers have previously been reported to increase IWL. 6 It 
stands to reason that an infant nursed in a radiant warmer would have a higher risk for 
hypernatraemia and that it might take longer to resolve, however in this study 
hypernatraemia resolved faster in those nursed in a radiant warmer compared to those 
nursed in an incubator which was unexpected. The possible explanation for this is that 
infants nursed under radiant warmers are covered with plastic or a heat shield to limit heat 
loss and IWL as part of the unit or hospital protocol.  
 
The number of infants who had cranial ultrasound done was small and this made it difficult 
to determine the incidence of IVH in infants with hypernatraemia. Reasons for the small 
number of ultrasounds include: a limited time available for the neonatologists to do the 
cranial sonars due to high volume of work and there is also the possibility that a cranial 
ultrasound was done on an infant but not documented in the file, especially those who are 
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found to be normal. Mortality in VLBWI is most likely multifactorial, therefore we looked 
at all-cause mortality rate as it is very difficult to assess mortality due to hypernatraemia on 
its own. The mortality rate in this cohort of babies was not much different from the overall 
mortality rate of 75% in VLBW infants in this neonatal unit. A common cause of mortality 
in VLBWI in this hospital is nosocomial sepsis, thus I would like to assume that even in 
this cohort, nosocomial sepsis was a common cause of death, as most of the deaths 
occurred at 7-28 days of life and yet the average time for resolution of hypernatraemia was 
44 hours.   
5.1 Study limitations 
The major limitation for this study is that it is a retrospective study. As a retrospective 
record review, there was a risk of not being able to retrieve all the files or information in 
files being incomplete. The retrieval rate in this study however was more than one had 
expected at 83.5%, therefore it gave one an opportunity to get fairly good information 
regarding incidence. Availability of data relies on the accuracy and completeness of nurses 
and doctors notes, which is most likely the case for the low number of available ultrasound 
reports. This is often compromised in a retrospective study. The accuracy of volume and 
type of fluids in this study was verified by matching information from doctors orders and 
what the nurse administered. Major difficulties experienced  was working out the rate of 
correction of hypernatraemia as one had to rely on times when blood specimens were 
received at the lab. The time that specimens were taken or when the results were acted 
upon were not always available.  
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6.0  CONCLUSION AND RECOMMENDATIONS 
In conclusion, hypernatraemia is a common problem among VLBWI admitted in the 
neonatal division at CHBAH.  Factors that might be contributing to high incidence of 
hypernatraemia could be related to use of sodium containing fluid from birth. The rate of 
correction of hypernatraemia was appropriate for most patients. Using a formula to correct 
free water deficit appears to be safe but a prospective study to confirm this is 
recommended as numbers in this study were small. Though correction of hypernatraemia 
appears to be appropriate in most patients, it is not clear as to what is the best fluid to use 
to correct hypernatraemia and how to calculate the volume. Therefore I recommend that 
prospective studies are conducted to assess the effect of using a sodium-free solution at 
birth on incidence of hypernatraemia, use of free-water deficit formula to correct 
hypernatraemia and lastly to accurately look at morbidities associated with 
hypernatraemia.  
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APPENDIX A: DATA COLLECTION 
 
Study Number: 
1. 
1.1. Age:    ________ years    
Maternal Details:   
1.2. Booked:                                   ………..  Yes     No   
1.3. Place of Delivery:    …………………………  CHBH        Clinic       Other 
hospital      Home  
1.4. Mode of delivery:       ……………………..  NVD        C/S         Breech         
   Forceps/Vacuum 
1.5. Gravidity: 
1.6. Maternal illness: PIH                            DM                      Other: 
1.7. HIV:  Pos     Neg      Unknown 
1.8. Antenatal steroids:               ………..  Yes     No    
 
2. 
2.1. Birth weight (grams): 
Infant Demographics:  
2.2. Gestational age: 
2.3. Apgar: 1 min                 5min 
2.4. Gender:  M                   F 
2.5. Time of birth: 
2.6. Date of birth: 
3. 
3.1. Name of fluid started at birth 
Fluid management at birth:  
3.1.1. Oral: ______________;   Intravenous: _________________ 
3.2. Volume started at birth (Total)  (mls/kg/day): 
3.2.1. Oral: __________ mls/kg/day, Intravenous: ____________ mls/kg/day 
 
4. 
4.1. Name of fluids at time of dx of Hypernatraemia    
Fluid management at time of diagnosis of hypernatraemia 
4.1.1.  Oral: ______________;   Intravenous: _________________ 
4.2. Volume of fluid at time of dx of hypernatraemia (Total) (mls/kg/day): 
43 
 
4.2.1. Oral:  _________ mls/kg/day, Intravenous: ___________ mls/kg/day 
 
5. 
5.1. Weight at time of response to hypernatraemia: ________ grams 
Fluid management in response to hypernatraemia 
5.2. Name of fluid ordered  
5.2.1. Oral: ______________;   Intravenous: _________________ 
5.3. Volume of fluid ordered (Total) mls/kg/day  
5.3.1. Oral:  _________ mls/kg/day, Intravenous: ___________ mls/kg/day 
5.4. Rate of increase of fluid (Total):  ______________ (mls/kg) 
5.4.1. Rate of increase calculated based on formula (600xwt (kg)x (1-
140/Curr.Na): …….  Yes       No   
5.4.2.  If the answer is NO, state if it is more or less:..  More    Less, & by what 
amount: ___mls/kg 
5.5. Name of fluid increased 
5.5.1. Oral: __________ mls/kg/day, Intravenous: ____________ mls/kg/day 
6. 
 
Electrolyte results: 
 At diagnosis 1st Result after 
Rx started 
2nd Result after 
Rx started 
3rd result 
after Rx 
started 
Na 
 
    
K 
 
    
Urea 
 
    
Creatinine 
 
    
Date U and E 
received 
 
    
Time U and E 
received at lab 
    
Type and vol 
fluid 
    
Rate of increase     
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7. 
7.1. Nursed in/under:  Incubator                                   Radiant warmer 
Environmental factors: 
7.2. Phototherapy (1st 72 hours):    ………..  Yes     No    
7.3. Ventilation: CPAP                             CMV 
 
8. 
8.1. IVH: 
Outcomes (<28days old) 
8.2. Survived/demised: 
8.2.1. Died during ↑Na:                                       ………..  Yes     No    
8.2.2. If no, died within 7 days:                           ………..  Yes     No    
8.2.3. Cranial sonar done:                                    ………..  Yes     No    
8.2.4. If yes, Grade IVH:  1    2    3    4 
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APPENDIX B: ETHICS CLEARANCE CERTIFICATE 
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APPENDIX C: "TURNITIN" REPORT 
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